Innovent Biologics, Inc. (IVBIY)
OTCMKTS
· Delayed Price · Currency is USD
29.00
+2.89 (11.07%)
At close: May 23, 2025
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of $17.07 billion as of June 10, 2025. Its market cap has increased by 107.70% in one year.
Market Cap
17.07B
Enterprise Value
16.38B
Revenue
1.29B
Ranking
n/a
PE Ratio
n/a
Stock Price
$29.00
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 2.36B to 17.07B, an increase of 621.88%. That is a compound annual growth rate of 34.85%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.60B |
| Veradigm | 747.25M |
| Nika Pharmaceuticals | 666.65M |
| Tian'an Technology Group | 637.25M |
| Elite Pharmaceuticals | 619.60M |
| Glass House Brands | 440.12M |
| CytoDyn | 437.04M |
| Northwest Biotherapeutics | 391.87M |